Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Most commonly used cancer therapies, particularly ionizing radiation and certain classes of cytotoxic chemotherapies, cause cell death by damaging DNA. Base excision repair (BER) is the major system responsible for the removal of corrupt DNA bases and repair of DNA single strand breaks generated spontaneously and induced by exogenous DNA damaging factors such as certain cancer therapies. In this review, the physico-chemical properties of the proteins involved in BER are discussed with particular emphasis on molecular mechanisms coordinating repair processes. The aim of this review is to apply extensive knowledge that currently exists regarding the biochemical mechanisms involved in human BER to the molecular biology of current therapies for cancer. It is anticipated that the application of this knowledge will translate into the development of novel effective therapies for improving existing treatments such as radiation therapy and oxaliplatin chemotherapy.

Original publication




Journal article


Mol Aspects Med

Publication Date





345 - 374


Antineoplastic Agents, Collagen Type XI, DNA Damage, DNA Glycosylases, DNA Ligases, DNA Repair, DNA-(Apurinic or Apyrimidinic Site) Lyase, DNA-Binding Proteins, DNA-Directed DNA Polymerase, Humans, Neoplasms, Nuclear Proteins, Polynucleotide 5'-Hydroxyl-Kinase, X-ray Repair Cross Complementing Protein 1